专题:Lipoproteins and Cardiovascular Health

This cluster of papers focuses on the efficacy and safety of cholesterol-lowering treatments, particularly statins, in the prevention and management of cardiovascular diseases. It includes meta-analyses, clinical trials, guidelines, and genetic studies related to LDL cholesterol, atherosclerotic cardiovascular risk, hypercholesterolemia, and the role of C-reactive protein. The cluster also explores the impact of statins on various patient populations and their pleiotropic effects.
最新文献
Polygenic Risk Based Detection and Treatment of Subclinical Coronary Atherosclerosis in the PROACT Clinical Trials

article Full Text OpenAlex

A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

article Full Text OpenAlex

The global burden of peripheral artery disease attributable to high fasting plasma glucose: a comprehensive analysis from 1990 to 2021 and projections to 2036

article Full Text OpenAlex

Semaglutide and tirzepatide effects on cardiovascular outcomes in people with overweight or obesity in the real world ( STEER )

article Full Text OpenAlex

Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial)

article Full Text OpenAlex

Oral triple combination lipid-lowering therapy and LDL cholesterol goal attainment: a simulation using the SANTORINI study cohort

article Full Text OpenAlex

The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk

article Full Text OpenAlex

Assessment of subclinical atherosclerosis with coronary calcium score in heterozygous familial hypercholesterolemia

article Full Text OpenAlex

The ‘10 commandments’ for the 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias

article Full Text OpenAlex

Lipoprotein(a), Remnant Cholesterol and Non-HDL-C in Women - Is it Different

article Full Text OpenAlex

近5年高被引文献
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

article Full Text OpenAlex 1152 FWCI231.7209

Pathophysiology of Atherosclerosis

review Full Text OpenAlex 837 FWCI66.0568

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

article Full Text OpenAlex 791 FWCI253.6348

The Role of Inflammation in Cardiovascular Disease

review Full Text OpenAlex 614 FWCI47.8635

Stroke genetics informs drug discovery and risk prediction across ancestries

review Full Text OpenAlex 564 FWCI101.0436

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

article Full Text OpenAlex 546 FWCI175.7419

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction

article Full Text OpenAlex 543 FWCI110.5233

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

article Full Text OpenAlex 476 FWCI94.8246

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

article Full Text OpenAlex 466 FWCI92.2088

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

review Full Text OpenAlex 452 FWCI61.1136